PoNS therapy shows promise for MS gait deficits
NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $3.84 ...
Helius exceeds stroke study enrollment goals
NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $2.8 ...
Nasdaq9d
Helius Medical Exceeds Enrollment Target For Stroke Pivotal Study
The stroke registrational program is designed to evaluate the safety and effectiveness of PoNS or Portable Neuromodulation Stimulator in improving balance and gait deficits in chronic stroke ...